Euroapi SAS
PAR:EAPI
Euroapi SAS
Cost of Revenue
Euroapi SAS
Cost of Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
E
|
Euroapi SAS
PAR:EAPI
|
Cost of Revenue
-€776.8m
|
CAGR 3-Years
0%
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
|
![]() |
Sanofi SA
PAR:SAN
|
Cost of Revenue
-€13.2B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
3%
|
|
![]() |
Ipsen SA
PAR:IPN
|
Cost of Revenue
-€618.7m
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-7%
|
|
![]() |
Vetoquinol SA
PAR:VETO
|
Cost of Revenue
-€275.1m
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-5%
|
|
![]() |
Virbac SA
PAR:VIRP
|
Cost of Revenue
-€459.8m
|
CAGR 3-Years
6%
|
CAGR 5-Years
1%
|
CAGR 10-Years
-1%
|
|
![]() |
Medincell SA
PAR:MEDCL
|
Cost of Revenue
-€896k
|
CAGR 3-Years
15%
|
CAGR 5-Years
7%
|
CAGR 10-Years
N/A
|
Euroapi SAS
Glance View
EUROAPI SA operates as a manufacturer and supplier of active pharmaceutical ingredient solutions for healthcare companies. The company is headquartered in Paris, Ile-De-France and currently employs 3,342 full-time employees. The company went IPO on 2022-05-06. The firm is engaged in the development, manufacture and supply of active-ingredient solutions to its healthcare partners. The company offers vitamin B12, prostaglandins, oligonucleotides, peptides, corticoids and hormones, anti-infectives, opiates (morphine, codeine, thebaine, etc. ), analgesics, etc. The firm also provides technologies and develops molecules through it’s Contract Development and Manufacturing Organization (CDMO). It’s CDMO services include Tides, Prostaglandins, Particle Engineering, Microbial Fermentation, Small Molecules Synthesis, Steroids and Hormones and Opiates & Controlled Substances. The company has production sites located in France, the United Kingdom, Germany, Italy and Hungary.
See Also
What is Euroapi SAS's Cost of Revenue?
Cost of Revenue
-776.8m
EUR
Based on the financial report for Dec 31, 2024, Euroapi SAS's Cost of Revenue amounts to -776.8m EUR.
What is Euroapi SAS's Cost of Revenue growth rate?
Cost of Revenue CAGR 5Y
1%
Over the last year, the Cost of Revenue growth was 9%.